Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-01-26 @ 8:10 PM
Study NCT ID:
NCT00862134
Status:
TERMINATED
Last Update Posted:
2013-01-10
First Post:
2009-03-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Proacta, Incorporated
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-Small Cell Lung Cancer | View |
Keywords: